{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T10:18:19Z","timestamp":1778581099130,"version":"3.51.4"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,12]]},"DOI":"10.7759\/cureus.108701","type":"journal-article","created":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T09:53:31Z","timestamp":1778579611000},"source":"Crossref","is-referenced-by-count":0,"title":["Lipid and High-Density Lipoprotein (HDL) Subfraction Changes in Premenopausal and Postmenopausal Women With Breast Cancer Receiving Hormonal Therapy"],"prefix":"10.7759","author":[{"given":"Anastasia","family":"Nikolakopoulou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konstantinos","family":"Nastos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitrios","family":"Papakonstantinou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kalliopi E","family":"Stavrati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vasiliki","family":"Michalaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georgios","family":"Koutroulis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikolaos","family":"Dafnios","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ioannis","family":"Papakonstantinou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christos","family":"Papadimitriou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1097\/CM9.0000000000003921","article-title":"Global burden and trends of breast cancer: GLOBOCAN 2022 estimates of incidence and mortality in 185 countries","volume":"139","author":"Gu H","year":"2026","unstructured":"Gu H, Wang R, Beeraka NM, et al.. Global burden and trends of breast cancer: GLOBOCAN 2022 estimates of incidence and mortality in 185 countries. Chin Med J. 2026, 139:404-14. 10.1097\/CM9.0000000000003921","journal-title":"Chin Med J"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3390\/curroncol30020142","article-title":"Risk of cardiovascular events and lipid profile change in patients with breast cancer taking aromatase inhibitor: a systematic review and meta-analysis","volume":"30","author":"Yoo JJ","year":"2023","unstructured":"Yoo JJ, Jung EA, Kim Z, Kim BY. Risk of cardiovascular events and lipid profile change in patients with breast cancer taking aromatase inhibitor: a systematic review and meta-analysis. Curr Oncol. 2023, 30:1831-43. 10.3390\/curroncol30020142","journal-title":"Curr Oncol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2008.09.007","article-title":"Effects of hormonal treatment on lipids in patients with cancer","volume":"35","author":"Filippatos TD","year":"2009","unstructured":"Filippatos TD, Liberopoulos EN, Pavlidis N, Elisaf MS, Mikhailidis DP. Effects of hormonal treatment on lipids in patients with cancer. Cancer Treat Rev. 2009, 35:175-84. 10.1016\/j.ctrv.2008.09.007","journal-title":"Cancer Treat Rev"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.exger.2021.111680","article-title":"The effect of tamoxifen on the lipid profile in women: a systematic review and meta-analysis of randomized controlled trials","volume":"159","author":"Alomar SA","year":"2022","unstructured":"Alomar SA, G\u0103man MA, Prabahar K, et al.. The effect of tamoxifen on the lipid profile in women: a systematic review and meta-analysis of randomized controlled trials. Exp Gerontol. 2022, 159:10.1016\/j.exger.2021.111680","journal-title":"Exp Gerontol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6602692","article-title":"The effects of aromatase inhibitors on lipids and thrombosis","volume":"93","author":"Bundred NJ","year":"2005","unstructured":"Bundred NJ. The effects of aromatase inhibitors on lipids and thrombosis. Br J Cancer. 2005, 93:23-7. 10.1038\/sj.bjc.6602692","journal-title":"Br J Cancer"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1210\/js.2019-00096","article-title":"Cardiometabolic effects of endocrine treatment of estrogen receptor-positive early breast cancer","volume":"3","author":"Cheung YM","year":"2019","unstructured":"Cheung YM, Ramchand SK, Yeo B, Grossmann M. Cardiometabolic effects of endocrine treatment of estrogen receptor-positive early breast cancer. J Endocr Soc. 2019, 3:1283-301. 10.1210\/js.2019-00096","journal-title":"J Endocr Soc"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s11010-005-2993-4","article-title":"Evaluation of serum lipids and high-density lipoprotein subfractions (HDL2, HDL3) in postmenopausal patients with breast cancer","volume":"268","author":"Michalaki V","year":"2005","unstructured":"Michalaki V, Koutroulis G, Syrigos K, Piperi C, Kalofoutis A. Evaluation of serum lipids and high-density lipoprotein subfractions (HDL2, HDL3) in postmenopausal patients with breast cancer. Mol Cell Biochem. 2005, 268:19-24. 10.1007\/s11010-005-2993-4","journal-title":"Mol Cell Biochem"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2025.0053","article-title":"NCCN Guidelines\u00ae insights: breast cancer, version 5.2025","volume":"23","author":"Gradishar WJ","year":"2025","unstructured":"Gradishar WJ, Moran MS, Abraham J, et al.. NCCN Guidelines\u00ae insights: breast cancer, version 5.2025. J Natl Compr Canc Netw. 2025, 23:426-36. 10.6004\/jnccn.2025.0053","journal-title":"J Natl Compr Canc Netw"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2017.277632","article-title":"HDL particle measurement: comparison of 5 methods","volume":"64","author":"Matera R","year":"2018","unstructured":"Matera R, Horvath KV, Nair H, Schaefer EJ, Asztalos BF. HDL particle measurement: comparison of 5 methods. Clin Chem. 2018, 64:492-500. 10.1373\/clinchem.2017.277632","journal-title":"Clin Chem"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-70178-3_12","article-title":"Role of estrogens in the regulation of liver lipid metabolism","volume":"1043","author":"Palmisano BT","year":"2017","unstructured":"Palmisano BT, Zhu L, Stafford JM. Role of estrogens in the regulation of liver lipid metabolism. Adv Exp Med Biol. 2017, 1043:227-56. 10.1007\/978-3-319-70178-3_12","journal-title":"Adv Exp Med Biol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacl.2012.03.001","article-title":"High-density lipoprotein subclasses and their relationship to cardiovascular disease","volume":"6","author":"Superko HR","year":"2012","unstructured":"Superko HR, Pendyala L, Williams PT, Momary KM, King III SB, Garrett BC. High-density lipoprotein subclasses and their relationship to cardiovascular disease. J Clin Lipidol. 2012, 6:496-523. 10.1016\/j.jacl.2012.03.001","journal-title":"J Clin Lipidol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25147856","article-title":"High-density lipoprotein subclasses and their role in the prevention and treatment of cardiovascular disease: a narrative review","volume":"25","author":"Chen Q","year":"2024","unstructured":"Chen Q, Abudukeremu A, Li K, et al.. High-density lipoprotein subclasses and their role in the prevention and treatment of cardiovascular disease: a narrative review. Int J Mol Sci. 2024, 25:10.3390\/ijms25147856","journal-title":"Int J Mol Sci"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.629666","article-title":"Metabolic syndrome and breast cancer: prevalence, treatment response, and prognosis","volume":"11","author":"Dong S","year":"2021","unstructured":"Dong S, Wang Z, Shen K, Chen X. Metabolic syndrome and breast cancer: prevalence, treatment response, and prognosis. Front Oncol. 2021, 11:10.3389\/fonc.2021.629666","journal-title":"Front Oncol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-15-2197","article-title":"AMPK activation and metabolic reprogramming by tamoxifen through estrogen receptor-independent mechanisms suggests new uses for this therapeutic modality in cancer treatment","volume":"76","author":"Daurio NA","year":"2016","unstructured":"Daurio NA, Tuttle SW, Worth AJ, et al.. AMPK activation and metabolic reprogramming by tamoxifen through estrogen receptor-independent mechanisms suggests new uses for this therapeutic modality in cancer treatment. Cancer Res. 2016, 76:3295-306. 10.1158\/0008-5472.CAN-15-2197","journal-title":"Cancer Res"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-022-01299-y","article-title":"Short-term tamoxifen administration improves hepatic steatosis and glucose intolerance through JNK\/MAPK in mice","volume":"8","author":"Fang Z","year":"2023","unstructured":"Fang Z, Xu H, Duan J, et al.. Short-term tamoxifen administration improves hepatic steatosis and glucose intolerance through JNK\/MAPK in mice. Signal Transduct Target Ther. 2023, 8:10.1038\/s41392-022-01299-y","journal-title":"Signal Transduct Target Ther"},{"key":"ref16","article-title":"Effect of aromatase inhibitors on lipid metabolism, inflammatory response and antioxidant balance in patients with breast carcinoma","volume":"29","author":"Melichar B","year":"2009","unstructured":"Melichar B, Kal\u00e1bov\u00e1 H, Kr\u010dmov\u00e1 L, et al.. Effect of aromatase inhibitors on lipid metabolism, inflammatory response and antioxidant balance in patients with breast carcinoma. Anticancer Res. 2009, 29:3337-46.","journal-title":"Anticancer Res"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/473995-lipid-and-high-density-lipoprotein-hdl-subfraction-changes-in-premenopausal-and-postmenopausal-women-with-breast-cancer-receiving-hormonal-therapy","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T09:53:32Z","timestamp":1778579612000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/473995-lipid-and-high-density-lipoprotein-hdl-subfraction-changes-in-premenopausal-and-postmenopausal-women-with-breast-cancer-receiving-hormonal-therapy"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,12]]},"references-count":16,"URL":"https:\/\/doi.org\/10.7759\/cureus.108701","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5,12]]}}}